Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,430
datasets available to search
ShareScore release 0.9.0
Dataset results
3,430 results for “PD”
STRIVE: A Single-arm Phase 2 Study on Treatment of Lung Squamous Cell Carcinoma by Tiragolumab Plus Ivonescimab for Patients Who Progressed on Platinum Doublets and Anti-PD-1/PD-L1
ClinicalTrials.gov study NCT07038915. IPD Sharing: Not stated. Countries: 0. Publications: 0.
QUILT-3.046: NANT Melanoma Vaccine: Combination Immunotherapy in Subjects With Melanoma Who Have Progressed On or After Chemotherapy and PD-1/PD-L1 Therapy
ClinicalTrials.gov study NCT03167177. IPD Sharing: NO. Countries: 0. Publications: 0.
Prognostic Value of PD-L1 in NSCLC
ClinicalTrials.gov study NCT03078959. IPD Sharing: NO. Countries: 0. Publications: 0.
The Safety, Tolerability, PK, and PD of DWP213388 After SAD and MAD Administration in Healthy Adult Subjects
ClinicalTrials.gov study NCT05607589. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Real-world Study of Chidamide in Combination with PD-1/PD-L1 Antibodies and Anti-angiogenic Agents in Advanced MSS Colorectal Cancer
ClinicalTrials.gov study NCT06682247. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Hepatic RFA Increases T Cell Infiltraion and PD-L1 Expression in Primary Colorecatl Cancer
ClinicalTrials.gov study NCT02475889. IPD Sharing: Not stated. Countries: 0. Publications: 0.
18-month Study of Long-term Efficacy & Safety of Safinamide as add-on Therapy in Patients With Mid-late Stage PD
ClinicalTrials.gov study NCT01286935. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Efficacy and Safety of Transarterial Therapies+Donafenib + Anti-PD-1 Antibody for uHCC: A Retrospective Real-world Study
ClinicalTrials.gov study NCT05638438. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Recombinant Human Adenovirus Type 5 Injection Combined With PD-1 Monoclonal Antibody and Nab-paclitaxel in the Treatment of Patients With Liver Metastases From Malignant Melanoma
ClinicalTrials.gov study NCT05664139. IPD Sharing: NO. Countries: 0. Publications: 0.
QUILT-3.047: NANT Head and Neck Squamous Cell Carcinoma (HNSCC) Vaccine: Combination Immunotherapy in Subjects With HNSCC Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy
ClinicalTrials.gov study NCT03169764. IPD Sharing: NO. Countries: 0. Publications: 0.
Evaluation of The Efficacy And Safety of PD-1 + IL-2 Combined With Capox Treatment After Loop Colostomy Surgery in Left-sided Colorectal Cancer Patients Complicating Acute Obstruction
ClinicalTrials.gov study NCT06394791. IPD Sharing: NO. Countries: 0. Publications: 0.
Allogeneic Gamma-delta T Cells Combined With Targeted Therapy and Immunotherapy in a Phase 1 Clinical Trial of Hepatocellular Carcinoma Resistant to PD-1 Monoclonal Antibody
ClinicalTrials.gov study NCT06364800. IPD Sharing: NO. Countries: 0. Publications: 0.
Assessment of Safety and Efficacy of OPM-101 Combined With Anti-PD-1 in Patients With Advanced Melanoma Showing Resistance to Anti-PD-1
ClinicalTrials.gov study NCT07040436. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Dose-Ranging, Multicenter Polysomnography Trial of PD 0200390 in Elderly Subjects With Primary Insomnia
ClinicalTrials.gov study NCT00748592. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Golidocitinib Combined With P-GemOx Plus PD-1 Inhibitor Versus P-GemOx Plus PD-1 Inhibitor in First-Line Newly Diagnosed Advanced or Non-Nasal Extranodal NK/T-Cell Lymphoma
ClinicalTrials.gov study NCT07385989. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Clinical Application of PD-1 Inhibitor in Colorectal Cancer for Improving Survival
ClinicalTrials.gov study NCT06900686. IPD Sharing: NO. Countries: 0. Publications: 0.
PD-L1/PD-1 Inhibitors Plus Chemotherapy Versus Chemotherapy Alone for the Neoadjuvant Treatment of Limited-stage SCLC
ClinicalTrials.gov study NCT06375109. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
PD-1 Combined With Bevacizumab and PCSK-9 Inhibitor in Patients With Advanced NSCLC Who Have Progressed After Anti- PD- 1/L1 Therapy
ClinicalTrials.gov study NCT07014215. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Hyperprogression in PD-L1 ≥ 50% NSCLC: a Biomarker Guided Phase 2 Trial
ClinicalTrials.gov study NCT07274384. IPD Sharing: Not stated. Countries: 0. Publications: 0.
HAIC Combined With PD-L1 Plus Regorafenib in the Treatment of Advanced Hepatocellular Carcinoma After Immunotherapy Failure
ClinicalTrials.gov study NCT06375317. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.